TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TXG

10X Genomics Inc

Healthcare · Health Information Services

76.60$ -0.5% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns 10X Genomics Inc (TXG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.3% of the shares are freely tradable; institutional investors hold 113.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 113.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 98.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 18.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 120Mio.

Largest Shareholders

Institutions

Institutions TXG
Name Stake (%) Shares Change (%) Date
FMR Inc 13.62 17,740,972 +48.9 03/31/2026
ARK Investment Management LLC 8.99 11,717,317 -7.5 03/31/2026
BlackRock Inc 7.74 10,079,913 +0.7 03/31/2026
Vanguard Portfolio Management, LLC 5.31 6,912,936 +0.0 03/31/2026
Quantinno Capital Management LP 4.15 5,411,761 +16.0 03/31/2026
Vanguard Capital Management, LLC 4.04 5,269,586 +0.0 03/31/2026
Sumitomo Mitsui Trust Group Inc 3.22 4,194,627 -17.9 06/30/2026
Amova Asset Management Americas, Inc 3.22 4,192,517 -17.9 06/30/2026
The Goldman Sachs Group Inc 3.05 3,971,800 +28.7 03/31/2026

Funds

Funds TXG
Name Stake (%) Shares Change (%) Date
ARK Disruptive Innovation Full Composite 3.92 5,105,417 -27.1 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings TXG
Person Role Shares Value As of Type
Saxonov Serge Chief Executive Officer 1,075,249 82,364,073 $ Sep 1, 2026 direct
Hindson Benjamin J. See Remarks 488,182 37,394,741 $ Aug 24, 2026 direct
Stuelpnagel John R Director 328,436 25,158,198 $ Sep 3, 2026 direct
Taich Adam Chief Financial Officer 316,344 24,231,950 $ Sep 9, 2026 direct
Suliman Shehnaaz Director 29,515 2,260,849 $ Aug 24, 2026 direct
Teichmann Sarah A. Director 28,058 2,149,243 $ Aug 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 9, 2026 Taich Adam Chief Financial Officer Sell 13,754 65.26 897,550
Sep 9, 2026 Taich Adam Chief Financial Officer Sell 31,428 64.31 2,021,125
Sep 9, 2026 Taich Adam Chief Financial Officer Sell 1,206 63.68 76,795
Sep 3, 2026 Stuelpnagel John R Director Sell 6,174 62.61 386,533
Sep 3, 2026 Stuelpnagel John R Director Sell 6,814 62.11 423,205
Sep 3, 2026 Stuelpnagel John R Director Sell 7,012 60.66 425,333
Sep 1, 2026 Saxonov Serge Chief Executive Officer Other 100 0.00
Aug 26, 2026 Saxonov Serge Chief Executive Officer Sell 492 64.75 31,855
Aug 26, 2026 Saxonov Serge Chief Executive Officer Sell 6,494 63.98 415,465
Aug 26, 2026 Saxonov Serge Chief Executive Officer Sell 3,500 63.02 220,580
Aug 24, 2026 Saxonov Serge Chief Executive Officer Sell 18,545 63.02 1,168,775
Aug 24, 2026 Taich Adam Chief Financial Officer Sell 17,166 63.02 1,081,853
Aug 24, 2026 Hindson Benjamin J. See Remarks Sell 13,818 63.02 870,860
Aug 24, 2026 Suliman Shehnaaz Director Sell 1,646 63.97 105,289
Aug 24, 2026 Suliman Shehnaaz Director Sell 561 62.73 35,189
Aug 20, 2026 Saxonov Serge Chief Executive Officer Other 4,000 0.00
Aug 14, 2026 Teichmann Sarah A. Director Sell 2,273 57.15 129,902
Aug 13, 2026 Teichmann Sarah A. Director Sell 5,278 57.29 302,377
Aug 11, 2026 Stuelpnagel John R Director Sell 3,000 58.73 176,175
Aug 11, 2026 Stuelpnagel John R Director Sell 17,000 57.58 978,880

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?